chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My arm is so sore; I have a headache; This case was reported by a consumer via media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th September 2021 10:00, the patient received the 2nd dose of Shingrix. On 24th September 2021, less than a day after receiving Shingrix, the patient experienced pain in arm and headache. On an unknown date, the outcome of the pain in arm and headache were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and headache to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient just had second Shingrix vaccine at 10 am on the reporting date and his/her arm was so sore and had a headache.  The patient was asking if he/she could take an Aleve for that. The follow-up would not possible as no contact details were available.
I got the vaccine on Saturday ran a fever until Wednesday and then on Wednesday night my heart started acting really crazy and my pulse was off the charts. At the hospital in the ER they had to stop my heart something called Cardiac Aversion I believe. My pulse was 190 and  with rapidly fluctuations they told me I have a heart condition called  STV they believe I was born with the condition but most of the time it stays dormant sometimes for your whole life. Mine became active that night and there is really no good reason why the only thing I had done different was getting that Johnson & Johnson vaccine
Acute myocardial infarction assoc /w ischemic heart disease. Cardiogenic shock&congestive heart failure due to acute MI.Viral pneumonia assoc /w recent Inflenza vax complicated by 2ndary bacterial pneumonia leading to resp failure..see WORM
Shingles on R side of back/side; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Apr2021 at 13:45 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. The medical history included obesity. The patient's known allergies was reported as not applicable. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 15:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. On 09May2021, the patient experienced shingles on R side of back/side. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient received antiviral medicine (unspecified) as treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles on R side of back/side was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Received FLUZONE on 10/29/2008.  On 10/31/2008 in am, pt had taken NASONEX and in pm, pt reported broke - out in "hives";  which was raised, pink patches throughout body.   On 11/3/2008 pt to urgent care and received Rx for PREDNISONE, but denied taking PREDNISONE, had only been taking BENADRYL.  On 11/4/08 pt reported body of being cleared from "hives".
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 56-year-old female patient who received SHINGRIX (batch number B4C42, expiry date 25th April 2020). On 9th March 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, several months after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were reported as follows: Within a few months after receiving SHINGRIX, the patient developed Shingles. No additional information was provided.
Grand Mal seizure lasting approximately 5 minutes, foaming at the mouth, convulsions and unresponsive for 10 minutes.  Called 911, vitals checked out to be ok, went to emergency room, everything came back as normal, referred to a neurologist.  Went to neurologist had normal CT scan, EEG showed some abnormalities.
body sweats; bad headaches; Runny nose; his body was warm and the cheeks were warm.; This is a spontaneous report from a contactable consumer (patient self). A 33-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 06Jan2021 at 11:20 at single dose on right arm for COVID-19 immunisation. Medical history included kidney disorder. He was not allergic to peanuts. He did catch COVID and had a positive test back in Apr2020. He had not taken any antibody test. He had no issues with vaccines in the past. Concomitant medications included levothyroxine sodium (SYNTHROID), hydrochlorothiazide for kidney, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) (he didnt take this he need a refill). The patient developed bad headaches and body sweats on 07Jan2021.  The patient reported he had side effects after getting his first covid vaccine. He got the shot on 06Jan2021 and over night developed a bad headache, body sweats, and had to call out of work today. He stated that he was laying in bed after a hot shower. He received his 1st dose on 06Jan2021 at 11:20 in the morning. He had No symptoms the of receiving the vaccine. Now because he is a Volunteer Fire Fighter, he woke up at 2-3 AM today this morning (07Jan2021) and that's when the headache started, it was gradually increasing. He took a hot shower and that made it better behind the neck but now its worse. His body sweats when he was sleeping this morning, his body was warm and the cheeks were warm. He also added that he had a runny nose that started the same time as the headache. The body sweats were on and off, its like his body was trying to fight it. Outcome of event headaches, body sweats and runny nose was not recovered, outcome of other events was unknown.   Information about Lot/Batch number has been requested.
Swollen axillary lymph nodes; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Apr2022 at 18:00 as dose 3 (booster), single (Lot number: FF8841) at the age of 39 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: FHP020, Location of injection: Arm Left, Vaccine Administration Time: 17:00 PM), administration date: 29Oct2021, when the patient was 39-year-old, for covid-19 Immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: FP4554, Location of injection: Arm Left, Vaccine Administration Time: 06:00 PM), administration date: 08Oct2021, when the patient was 39-year-old. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 05Apr2022 at 12:00, outcome "not recovered", described as "Swollen axillary lymph nodes". The event "swollen axillary lymph nodes" required physician office visit. It was unknown if therapeutic measures were taken as a result of lymphadenopathy.  Additional information:  The patient did not receive any other medications within 2 weeks of vaccination.  The patient did not receive any other vaccines prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient not tested for COVID-19 vaccine.  Follow-Up (11Apr2022): Follow-up attempts are completed. No further information is expected.
Pt started to have red, swollen eyelids & upper cheeks after administration of varicella vaccine. No SOB. Pt was able to verbalize w/o any difficulties. Pt sent to urgent care for further evaluation.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Apr2022 at 01:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Breast Cancer" (unspecified if ongoing); "Osteoporosis" (unspecified if ongoing); "known allergies: PCN" (unspecified if ongoing). Concomitant medication(s) included: VALTREX oral. Past drug history included: Morphine, reaction(s): "known allergies: Morphine"; Codeine, reaction(s): "known allergies: Codeine"; Lactose, reaction(s): "known allergies: Lactose". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical information: The patient received other medication in 2weeks, Valtrex, via an oral route of administration. COVID 19 treatment was received with Paxlovid, Treatment start date: 06Jun2022, Administrator route: Oral. Pfizer BioNTech, vaccine lot unknown reason was misplaced or discarded.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the events Drug ineffective and Covid-19 and the suspect drug cannot be excluded. The case will be reassessed once new information is available.
Patient has been experiencing metallic taste, tongue feeling like sandpaper, and upset stomach. Patient still has upset stomach but the metallic taste has disappeared and the tongue feeling like sandpaper is not as severe as it was initially. Patient has tried Prilosec to relieve upset stomach with no relief and has contacted MD with no new orders. Suggested for patient to take Mylanta, will follow up on 4/4/21. Patient feeling much better, has taken Mylanta as requested, no longer has upset stomach.
Case number PHEH2014US010898, is an initial spontaneous report from a pharmacist received on 27 May 2014 and a follow up information was received from the pharmacist on 09 Jul 2014. This report refers to a 19 year old female patient. Her historical condition and concomitant medications were not reported. The pharmacy intern reported that he patient erroneously received MENVEO (batch number: A11052/A13051) intramuscularly in the right deltoid at a dose of 0.5 ml. that was reconstituted with an expired liquid Men CYW-135 component on 27 May 2014. It was reported that the Men A vial had not expired. No adverse event was reported following these administration error. Follow up information was received from the pharmacist on 09 Jul 2014: Updated vaccine dosage and site of vaccine administration.
flu; Initial information received on 05-Nov-2020 regarding an unsolicited non-valid non-serious social media case through global digital media received from a patient.  This case involves a patient of unknown demographics who reported of suffering from flu (influenza), after receiving INFLUENZA VACCINE.  The patient's medical history included flu.  Information about past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route at an unknown administration site as a prophylactic vaccination.  On an unspecified date, (latency unknown) after the administration of vaccine, the patient reported of suffering from flu (influenza). The patient also reported that after each administration of INFUENZA VACCINE, the patient suffers from flu.   No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information regarding the batch number of the case.
Only shingrix adjuvant was administered; Only shingrix adjuvant was administered; This case was reported by a other health professional and described the occurrence of inappropriate preparation of medication in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The reporter was vaccine coordinator. The age at vaccination was not reported.  The reporter stated that the patient was administered with only shingrix adjuvant, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter asked how to proceed with vaccination. The reporter consent to follow up.
Localized erythema and slight tenderness to palpation at site of injection noted by patient 6 days after injection. Pain 1/10.
POSSIBLE ALLEGIC REACTION TO AMOXIL VS IMMUNIZATIONS. EYES AND FACE SWOLLEN. PATIENT CAME IN ON 5/9/11. NO FEVER NO SOB NO COUGH SWELLING DECREASED MOM STOPPED ANTIBIOTICS
This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a elderly male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not provided. No information on first dose of SHINGRIX was provided. Consent to follow up was provided. For tolerance to 2nd dose please refer case US2018203342.
Hot face and neck, nausea, body aches, fatigue, extremely sore arm around injection site couldn?t lift it
Shot at 10:30 AM Thursday, experienced intense soreness in right arm (far worse than the 1st shot in left arm) and by mid-afternoon headache. Overnight woke with fever, chills, headache and sore arm making sleep impossible. Ill all day Friday - fever, chills, fatigue, no appetite, headache, arm soreness.  Friday evening awoke with intense pain in right arm pit, breast, upper ribs - extremely swollen lymph nodes (size of avocado).  Extremely tender and sore.  Pain continued throughout Saturday, Sunday, and now into Monday.  Also still fatigued and feeling run down.
9APR98 acquired pox x 3-little itching;no other illness-no known exposure;
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. Patient's concurrent condition and medical history was not reported. On 10-DEC-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB 2.5/0.5 (units unspecified) lot # L029631, Expiry date: 14-AUG-2017 (dose, route, therapy type not reported). No adverse effects were reported. No further information was provided. This is one of the two reports from the same reporter. Additional information has been requested.
Dizziness, clammy, BP 104/61 (pulse 84), O2 sat 100%.
Patient reported lump in throat & scratchyness indicative of a similar anaphylactic reaction that she had to wasps. She received an Epi pen within 10 min of vaccine administration. Pt given prednisone in ER.
Pt states arm started tingling the day after. She has been having increased tingling in numbness in arm since then. Pt plans to contact PCP.
FROM FRIDAY FEBRUARY THE 25TH UNTIL WEDNESDAY MARCH THE 2ND, I HAD THE CHILLS ON AND OFF.  EVERY DAY I HAD A TEMP RANGING FROM 100.2-101.3 IN THE EVENING. I HAD BODY ACHES THAT KEPT ME UP AT NIGHT WHICH WAS MORE SEVERE THE 1ST 48HOURS (FRIDAY NIGHT AND SATURDAY NIGHT). THEREAFTER THE BODY ACHES AND CHILLS WERE INTERMITTENT. THE MOST IMPORTANT AND MOST PAINFUL EXPERIENCE WAS THAT MY LEFT UNDER ARM WAS SWOLLEN AND EXTREMELY PAINFUL. UNFORTUNATELY THE PAIN I HAD UNDER MY ARM RADIATED TO THE SIDE OF MY LEFT BREAST. I HAD VERY LIMITED RANGE OF MOTION SECONDARY TO THE PAIN AN THE SWELLING. I WAS VER CONCERN, SO I WENT TO URGENT CARE. AN ULTRASOUND WAS DONE TO RULE AN ABSCESS AND FLUID BUILD UP. THE RESULTS WERE NEGATIVE. I ALSO HAD A PCR/RAPID COVID TEST AND THAT WAS ALO NEGATIVE. LABS WERE DRAWN AND EKG WAS OBTAIN, ALL WERE BENIGN. FROM THE 2/25/2022-3/2/2002 I HAVE BEEN TAKING MOTRIN 800 AND TYLENOL EVERY 6 HOURS TO HELP WITH THE PAIN WHICH HELPED MINIMALLY. FROM THE 3ND OF MARCH UNTIL PRESENTLY, I AM STILL EXPERIENCING PAIN UNDER MY LEFT ARM BUT THE SWELLING HAVE GONE DOWN TREMENDOUSLY. EVERY SO OFTEN I WOULD EXPERIENCE SOME ACHES HERE AND THERE AND SOME CHILLS BUT NO FEVER. PRESENTLY, I CAN'T REALLY SLEEP ON MY LEFT SIDE BECAUSE OF THE DISCOMFORT TO MY UNDER ARM
Head aches, head ache for more than 3 weeks; Had at least 3 nosebleeds in the last month out of nowhere; Rash on the upper neck and around her chest and around her blossom; Reporter is concerned that the vaccine was tampered with or given the wrong dose; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Head aches, head ache for more than 3 weeks), EPISTAXIS (Had at least 3 nosebleeds in the last month out of nowhere), RASH (Rash on the upper neck and around her chest and around her blossom) and INCORRECT DOSE ADMINISTERED (Reporter is concerned that the vaccine was tampered with or given the wrong dose) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Head aches, head ache for more than 3 weeks), EPISTAXIS (Had at least 3 nosebleeds in the last month out of nowhere), RASH (Rash on the upper neck and around her chest and around her blossom) and INCORRECT DOSE ADMINISTERED (Reporter is concerned that the vaccine was tampered with or given the wrong dose). The patient was treated with IBUPROFEN (ADVIL MIGRAINE) ongoing since an unknown date for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (Head aches, head ache for more than 3 weeks), EPISTAXIS (Had at least 3 nosebleeds in the last month out of nowhere) and RASH (Rash on the upper neck and around her chest and around her blossom) outcome was unknown and INCORRECT DOSE ADMINISTERED (Reporter is concerned that the vaccine was tampered with or given the wrong dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, White blood cell count: decreased (abnormal) white blood cells decreased.         No concomitant medications were provided. Steroid cream for the rash was taken by the patient to alleviate the symptoms experienced.   Reporter did not allow further contact
Patient received a dose of a Pfizer vaccine after previously receiving a Moderna vaccine. Patient monitored for 30 minutes after the vaccine and remains asymptomatic. Will follow up with patient regarding completing series based on manufacturer recommendation following speaking with Pfizer/Moderna later today
Patient states that shortly after receiving spikevax she started experiencing all over body aches and burning on the top of her feet and toe joints (she believes this may be a flare up of fibromyalgia).  She also has a rash and itching at site of the injection.
Tdap given IM left deltoid (non-dominant arm) on 11/29/06. On 12/3/06 pt noticed sore arm at injection site, tender left armpit. URI symptoms also present w/acute bronchitis and sinusitis diagnosed. For injection site discomfort recommended Tylenol. Given abx, steroid inhaler and beta-2 agonist inhaler for bronchitis in a smoker with pending dental work.  Influenza shot given IM right deltoid without any discomfort. URI symptoms as noted above.
Moderna COVID-19 Vaccine . During the night, I woke up in so much paid that I was screaming. It felt like my whole body was covered in needles. I would not find a comfortable position to sleep in. It hurt to have any type of clothing on. My arms, torso and legs were the worst. I could feel the pain coming toward my right knee and once again I was screaming and crying. I spent the better part of Monday, April 5, 2021 in the hospital ER. I have lost 2 days of pay and I still hurt in both arms. I have been thru enough scary situations but never have I ever felt anything like this!
VACCINE DOSE #2 GIVEN 19 DAYS S/P DOSE #1 (23 MARCH 2021).
headache; body aches; chills; This is a spontaneous report from a contactable consumer (patient).  A 50-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration on 23Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history was none. There were no concomitant medications. The evening of 23Apr2021 the patient begun to experience chills; he woke up on 24Apr2021 (Saturday morning) with very bad body aches and headache that lasted all day. Sunday he continued to experience a headache. Outcome of the event headache was not recovered while outcome of the other events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Started the evening after her 4 month shots she slept for about two days wouldn?t eat much, then on June 13 she started screaming non stop day and night for a few days, throwing up, not sleeping, pooping blood. That lasted a few days, around June 20 noticed she wasn?t as vocal with us. June 22nd she is still very fussy not her normal self
SORE ARM; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced sore arm. Laboratory data (dates unspecified) included: Antibody test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious. This case, from the same reporter is linked to 20211017191.
Pfizer-BioNTech COVID-19 Vaccine EUA: patient hospitalized with COVID-19 infection leading to pneumonia . Administered oxygen and steroids and discharged to home medically stable.
headache, fatigue, back of rt ocular pain, mild chill, cough, dizzy and nauseated
48Hrs following I had stomach pain and I was cramping . I had got diverticulitis.